Part of our Complete Guide to Research Peptides.

Semax Research Overview: What the Literature Says

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), an analog of adrenocorticotropic hormone fragment ACTH(4-10). Among research peptides studied for neurotrophic signaling, it has one of the more extensive bodies of rodent-model literature, with research dating back several decades.

What the Research Covers

• BDNF/TrkB neurotrophic signaling — studied for its interaction with brain-derived neurotrophic factor pathways in rat hippocampus models, with research reporting measurable increases in BDNF protein and mRNA levels following administration.
• Cognitive function research — referenced in rodent studies examining learning and memory-related processes, including conditioned avoidance reaction models.
• Neuroprotection — research has explored its role in models of cerebral ischemia and neuronal stress, examining its effects on neurotrophic factor and receptor expression.
• Gene expression research — studies using real-time PCR analysis have examined region-specific changes in neurotrophin gene expression across rat brain regions including hippocampus, frontal cortex, brainstem, and cerebellum.

One rat hippocampus study reported that a single intranasal application of Semax resulted in a measurable increase in BDNF protein and mRNA levels alongside increased TrkB receptor phosphorylation, with treated animals also showing changes in conditioned avoidance reaction behavior. For a detailed look at this research, see: Semax, an analog of ACTH(4–10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus (ScienceDirect).

Semax has a substantial body of preclinical literature, particularly around its neurotrophic signaling mechanisms in rodent models, making it a frequently referenced compound in neuroscience-adjacent peptide research.

Purity Considerations

HPLC verification, alongside mass spectrometry identity confirmation, helps confirm purity and correct synthesis for consistent, reproducible research results across batches. Our Semax, 10mg is supplied with third-party HPLC verification for every batch.

Handling and Reconstitution

Semax is supplied in lyophilized form and requires reconstitution with an appropriate diluent before use in a research application. See our Reconstitution Guide for general laboratory technique.

Frequently Referenced Study Areas for These Research Peptides

Researchers studying Semax often reference comparative work examining related ACTH-fragment analogs, such as ACTH(6-9)PGP and ACTH(7-10)PGP, to help isolate which structural components of the peptide are responsible for specific neurotrophic effects. This comparative approach has been useful for characterizing structure-activity relationships within this broader class of ACTH-derived compounds.

Time-course studies examining Semax administration at multiple intervals (from 20 minutes to 24 hours post-treatment) have also helped researchers map the temporal dynamics of neurotrophin gene expression changes across different rat brain regions, providing a more complete picture of how quickly and how long these signaling changes persist in research models.

Because much of the foundational Semax research originated from Russian research institutions, researchers newer to this compound may find it useful to cross-reference findings against more recent studies examining its neuroprotective properties in models of hypoxia and cerebral ischemia. This growing body of comparative literature helps contextualize earlier findings within the broader framework of neurotrophic factor research and ACTH-derived peptide pharmacology.

Researchers designing experiments with Semax should note that most published effects come from intranasal administration in rodent models, a delivery route that researchers have found allows the peptide to reach central nervous system tissue relatively efficiently compared to some other delivery methods studied for similar compounds. This route-specific consideration is worth accounting for when comparing results across different experimental designs in the broader ACTH-analog research literature more generally.

This page is provided for general research and educational reference only. It is not a substitute for reviewing primary published literature, and it is not intended to suggest any use in humans or animals. All products sold by PNW Peptides LLC are supplied strictly for laboratory research use (RUO) and are not for human or veterinary consumption. See our RUO Disclaimer.